In particular, Wnt5a is frequently epigenetically inactivated in CRC, showing tumor-suppressive activity through counteraction of the canonical Wnt/beta-catenin signaling pathway and CRC metastasis47,48. The gene discussed is CTNNB1; the disease is neoplasm.